#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Turner's syndrome Transient ischaemic attack Rosai-Dorfman syndrome Wolfram syndrome Neuroendocrine carcinoma of the skin Hypereosinophilic syndrome Gaucher's disease type I Pulmonary alveolar haemorrhage Ventricular tachycardia Solitary fibrous tumour Demyelination Hereditary hypophosphataemic rickets Shprintzen-Goldberg syndrome Intracranial germ cell tumour Hereditary ataxia More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Trials in Disease Bronchiolitis obliterans syndrome – Trials in Disease Congenital hypotransferrinaemia – Trials in Disease Atypical haemolytic uraemic syndrome – Life with Disease Hereditary angioedema – Basic Information Hairy cell leukaemia recurrent – Trials in Disease Andersen-Tawil syndrome – Life with Disease Angiosarcoma non-metastatic – Basic Information Gastrointestinal stromal tumour Hereditary ataxia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lanreotide Demeclocycline Hydrochloride Terbinafine Kbp-336 CAL101 Mosliciguat L-Acetylleucine Taldefgrobep Alfa NORGESTIMATE Anitocabtagene Autoleucel Secale Cereale Apraglutide Tisotumab Vedotin ALLO-QUADCAR01-T Dexamfetamine Sulfate VANADIUM OXIDE SULFATE Paclitaxel Obaluronate Hydralazine Hydrochloride Midazolam ANERATRIGINE MESILATE More therapies…

    Learn about Your Condition

    Hepatobiliary cancer Lung adenocarcinoma stage IV Dementia Alzheimer's type Hand dermatitis Ovarian cancer metastatic Diabetic retinal oedema Mantle cell lymphoma stage II Mucous membrane pemphigoid Anxiety Tumour thrombosis Lung transplant rejection Drug eruption Gastric cancer Procedural headache Cervix carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uveal melanoma

  • Study on the Effects of Sitravatinib and Tislelizumab for Patients with Metastatic Uveal Melanoma and Liver Metastases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Sitravatinib Malate
    • Tislelizumab
    Spain

  • Study of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Dacarbazine
    • Darovasertib
    • Crizotinib
    Belgium France Germany Italy The Netherlands Poland +1

  • Study of AloCelyvir for Patients with Metastatic Uveal Melanoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
    Spain

  • Study on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions

    Not recruiting

    3 1
    Investigated Diseases:
    • Choroid melanoma
    • Malignant neoplasm of choroid
    • Uveal melanoma
    Investigated Drugs:
    • Belzupacap Sarotalocan
    Austria Belgium Czechia Denmark France Germany +6

  • Study of Darovasertib for Patients with Localized Uveal Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Ethinylestradiol
    • Darovasertib
    • Metformin Hydrochloride
    France Germany Italy The Netherlands
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!